SCHEMBL14967151

SCHEMBL14967151

Cc1cc(C)c(CNC(=O)c2ccc([C@@H](C)Oc3ccccc3)c(Cl)c2)c(O)n1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
LMNA P02545 2/20 0.39
MAPT P10636 1/20 0.39
KLKB1 P03952 9/20 0.38
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
TP53 P04637 1/20 0.38
MAP4K1 Q92918 1/20 0.38
OPRM1 P35372 1/20 0.37
OPRK1 P41145 1/20 0.37
PPARG P37231 1/20 0.37
EPHX2 P34913 1/20 0.37
PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14967364 1.00 KDM4E (0.41) KDM4ESMN1; SMN2LMNAMAPTKLKB1
SCHEMBL14967281 1.00 KDM4E (0.41) KDM4ESMN1; SMN2LMNAMAPTKLKB1
SCHEMBL14966826 0.91 SMN1; SMN2 (0.41) KDM4ESMN1; SMN2LMNAMAPTKLKB1
SCHEMBL14967045 0.91 SMN1; SMN2 (0.41) KDM4ESMN1; SMN2LMNAMAPTKLKB1
SCHEMBL14966641 0.89 SMN1; SMN2 (0.40) KDM4ESMN1; SMN2MAPTKLKB1ALDH1A1
SCHEMBL14967484 0.89 SMN1; SMN2 (0.40) KDM4ESMN1; SMN2MAPTKLKB1ALDH1A1
SCHEMBL14967162 0.89 SMN1; SMN2 (0.40) KDM4ESMN1; SMN2MAPTKLKB1ALDH1A1
SCHEMBL14967406 0.85 SMN1; SMN2 (0.45) KDM4ESMN1; SMN2LMNAMAPTKLKB1
SCHEMBL14966658 0.85 SMN1; SMN2 (0.45) KDM4ESMN1; SMN2LMNAMAPTKLKB1
SCHEMBL14967419 0.85 SMN1; SMN2 (0.45) KDM4ESMN1; SMN2LMNAMAPTKLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2780014-A1 MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF Constellation Pharmaceuticals, Inc. (US) 2014-09-24 EP disclosed
WO-2013075083-A1 MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF CONSTELLATION PHARMACEUTICALS (US) 2013-05-23 WO disclosed